Trials / Completed
CompletedNCT02829892
Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment.. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light nighttime sleep of residents.
Detailed description
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment. In 2014, the Cochrane published a systematic review of the literature over the last 20 years concerning the use of light therapy in patients with a AD. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light therapy (from 5 a.m to 10 p.m) on nighttime sleep of residents. Secondary objectives were the study of sleep time on the day, anxiety by the COVI scale and behavioral disorders by the NPI scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Light therapy | 14-days exposure with an innovative ambient light |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2016-07-12
- Last updated
- 2016-07-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02829892. Inclusion in this directory is not an endorsement.